How We Think - Biosimilars

These are the posts from the How we think section that have been tagged with Biosimilars.

To see all tags used in our posts, click here.

Blue-Latitude-Health-branded-altitude-image

Biosimilars - the Brexit of the pharmaceutical industry?

Jenna Earl|13th June 2016

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities of Britain exiting the EU (Brexit).

read more

sketchnote-blue-latitude-health-portfolio-planning

Bigger than brand: Portfolio positioning for pharma

Jenna Earl|29th September 2015

With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

read more

clinic-medical-scientist-medicine-lab

Tackling biosimilars – how to handle the threat to pharma brands

Mark Assenti|23rd September 2015

Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

read more

microscope-dna-Blue-Latitude-Health-biomarkers-in-marketing

Use of biomarkers in marketing

Mark Assenti|12th March 2015

The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by. 

Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.

read more